TECX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While TECX seems to be doing ok healthwise, there are quite some concerns on its profitability. TECX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

TECX had negative earnings in the past year.
TECX had a negative operating cash flow in the past year.
TECX had negative earnings in each of the past 5 years.
TECX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -24.30%, TECX is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
The Return On Equity of TECX (-25.16%) is better than 79.43% of its industry peers.

		Industry Rank	Sector Rank
ROA	-24.3%
ROE	-25.16%
ROIC	N/A

ROA(3y)-71.59%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TECX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for TECX has been increased compared to 1 year ago.
Compared to 1 year ago, TECX has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 21.79 indicates that TECX is not in any danger for bankruptcy at the moment.
TECX has a Altman-Z score of 21.79. This is amongst the best in the industry. TECX outperforms 90.10% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that TECX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.00, TECX perfoms like the industry average, outperforming 52.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	21.79

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

TECX has a Current Ratio of 29.15. This indicates that TECX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 29.15, TECX belongs to the top of the industry, outperforming 97.90% of the companies in the same industry.
A Quick Ratio of 29.15 indicates that TECX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 29.15, TECX belongs to the best of the industry, outperforming 97.90% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	29.15
Quick Ratio	29.15

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.37% over the past year.

EPS 1Y (TTM)60.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%15%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, TECX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.26% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y48.82%

EPS Next 2Y18.63%

EPS Next 3Y10.26%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TECX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TECX. No positive earnings are expected for the next year.